Allied Market Research


Nasal Cannula Market

Nasal Cannula Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type, by Application and, by End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Nasal Cannula Market Outlook - 2027

Nasal cannulas are medical devices used when people are unable to get sufficient oxygen to keep their body functioning optimally, whether that's due to a condition like chronic obstructive pulmonary disease (COPD), another respiratory disorder, or an environmental change. Nasal cannulas (and the oxygen sources they connect to) are lightweight, easy to use, and affordable. They may be used in a variety of hospital settings, at home, or on-the-go. A nasal cannula is a small, flexible tube that contains two open prongs intended to sit just inside your nostrils. The tubing attaches to an oxygen source and delivers a steady stream of medical-grade oxygen to your nose. The oxygen concentration used with nasal cannulas is relatively low, though high-flow cannulas do exist; these allow output that's similar to that of a continuous positive airway pressure systems (CPAP). Nasal cannulas are less invasive than other oxygen delivery systems, most of which involve a face mask. In contrast, nasal cannulas generally don't prohibit regular eating and talking, and they are pretty portable

Covid-19 Scenario analysis:

The novel coronavirus pneumonia (COVID-19), which was first detected in Wuhan City, has now became a pandemic that affecting patients around the world. Particularly, the community patient population are at high risk of infection and are facing potential failure of proper medication use during the pandemic. Human-to-human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission has been established, with >3300 clinicians reported to be infected in China and >1116 clinicians infected in Italy, where 13 882 cases were confirmed by 13 March 2020. Room surfaces in the vicinity of coronavirus disease 2019 (COVID-19) symptomatic patients and clinicians' protective equipment were found to be contaminated. The primary strategy for COVID-19 patients is supportive care, including oxygen therapy for hypoxemic patients, in which high-flow nasal cannula (HFNC) has been reported to be effective in improving oxygenation. Hence the pandemic has created a need for excessive supply of nasal cannula and so the market is facing high demand during the pandemic.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:


Increase in respiratory disorders:

About 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year, making it the third leading cause of death worldwide. About 334 million people suffer from asthma, the most common chronic disease of childhood affecting 14% of all children globally. Pneumonia kills millions of people annually and is a leading cause of death among children under 5 years old. Over 10 million people develop tuberculosis (TB) and 1.4 million die from it each year, making it the most common lethal infectious disease. Lung cancer kills 1.6 million people each year and is the most deadly cancer. Globally, 4 million people die prematurely from chronic respiratory disease. At least 2 billion people are exposed to indoor toxic smoke, 1 billion inhale outdoor pollutant air and 1 billion are exposed to tobacco smoke. This increased number of respiratory malfunction has increased the demand for nasal cannula in the market.

Increased flexibility for patients: 

Nasal cannulas are used to deliver oxygen when a low flow, low or medium concentration is required, and the patient is in a stable state. They deliver oxygen in a variable manner; this means the amount of oxygen inspired depends on the patient’s breathing rate and pattern.  In acute situations patients may need a higher concentration of oxygen and a non-rebreathe mask or simple oxygen mask is often used.  Flow rates of 1-4 liters per minute are used with nasal cannulas, equating to a concentration of approximately 24-40% oxygen. Flow rates of up to 6 liters can be given but this will often cause nasal dryness and can be uncomfortable for patients (British Thoracic Society, 2008). The advantages of nasal cannulas for patients who have chronic stable respiratory problems is that it is possible to eat, drink and talk while using them; they also reduce the risk of carbon dioxide rebreathing. 


Side effect of using a nasal cannula is ensuing nasal dryness, which is fairly common as cold, dry oxygen is streamed into your nostrils.

Several risks to consider before using any form of supplemental oxygen. Namely, long-term use has been linked to lung damage, eye damage (resulting from pressure build-up), and a condition called pulmonary oxygen toxicity, in which too much oxygen exists in the body and may result in damage to airways.

Regional analysis:

North America is will mostly dominate nasal cannula market due to the preference for non-invasive ventilation (NIV) and continuous positive airway pressure (CPAP) devices has augmented rapidly in home care settings for patients suffering from respiratory diseases in North America. This has stimulated key manufacturers to increase production of high-flow nasal cannula devices, thus increasing the market share. Asia-Pacific shows impressive growth prospects for the high-flow nasal cannula market during the forecast period. Increasing population, degraded air quality and growing smoking prevalence have increased the number of respiratory disease cases. This has augmented the market for high-flow nasal cannula market in Asia-Pacific too.

Key benefits of the report:

  • This study presents the analytical depiction of the global Nasal Cannula industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Nasal Cannula market share.
  • The current market is quantitatively analyzed to highlight the global Nasal Cannula market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global Nasal Cannula market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Nasal Cannula Market research report:

  • What are the leading market players active in the Nasal Cannula market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Nasal Cannula Market Report Highlights

Aspects Details
By Type
  • Curved prong
  • Flared prong
  • Curved and Flared prong
  • Straight prong
By Application
  • Asthma
  • COPD
  • Sleep apnea
  • Cystic fibrosis
  • Pneumonia
  • Cardiovascular Surgery
  • Cosmetic/Plastic Surgery
  • Diabetes treatment, Ophthalmology, Gynaecology, and Neurology
By End Users
  • Hospitals
  • Ambulatory surgical centres
  • Home care settings
  • Long term care centres
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Terumo Corporation,, Flexicare Medical,, Medtronic PLC,, Sorin Group,, Fisher and Paykel Healthcare Ltd.,, Medin Medical innovations,, Teleflex, Salter Labs,, Vapotherm, Smiths Medical,

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Nasal Cannula Market

Global Opportunity Analysis and Industry Forecast, 2023-2032